FAITH ALCE: Open Payments
NPI 1871119040 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 17 payments from 5 companies in 2025. Trend: 2023 $335 · 2024 $186 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $150 |
| ABBVIE INC. | 3 | $122 |
| Vanda Pharmaceuticals Inc. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Lilly USA, LLC | 1 | $17 |
Products named: QULIPTA, Rybelsus, FANAPT, CAPLYTA, ZEPBOUND, Ozempic, VRAYLAR, UBRELVY.
Industry payments across GA — which companies pay providers there.
